REGN EBITDA
$5.75BTTM · USD
Period ending:
REGN FY EBITDAUSD
$9.67B-$170.53M
1990-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
REGN ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| 5,818,200,000 | |
| 5,318,000,000 | |
| 4,693,300,000 | |
| 5,259,600,000 | |
| 9,669,300,000 | |
| 4,103,200,000 | |
| 2,669,600,000 | |
| 2,729,900,000 | |
| 2,249,097,000 | |
| 1,441,755,000 | |
| 1,314,247,000 | |
| 865,805,000 | |
| 801,001,000 | |
| 496,665,000 | |
| -170,528,000 | |
| -75,663,000 | |
| -55,368,000 | |
| -61,320,000 | |
| -82,070,000 | |
| -76,515,000 | |
| -67,896,000 | |
| 69,236,000 | |
| -91,513,000 | |
| -113,499,000 | |
| -79,606,000 | |
| -20,855,000 | |
| -20,400,000 | |
| -9,500,000 | |
| -9,300,000 | |
| -11,200,000 | |
| -1,700,000 | |
| -25,000,000 | |
| -35,700,000 | |
| -16,300,000 | |
| -8,800,000 | |
| -3,000,000 |
Compare ebitda
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) ebitda
- Johnson & Johnson (JNJ) ebitda
- AbbVie (ABBV) ebitda
- UnitedHealth Group (UNH) ebitda
- Merck & Co. (MRK) ebitda
- Thermo Fisher Scientific (TMO) ebitda
- Amgen (AMGN) ebitda
- Gilead Sciences (GILD) ebitda
All REGN financial metrics · REGN stock overview · How to interpret financial metrics
